Seer to Participate in the TD Cowen 45th Annual Health Care Conference

Rhea-AI Summary

Seer (Nasdaq: SEER), a pioneering life sciences company focused on proteomics platform commercialization, has announced its participation in the TD Cowen 45th Annual Healthcare Conference in Boston, MA.

The company's management team will engage in a fireside chat scheduled for Tuesday, March 4th at 11:50 a.m. Eastern Time (8:50 a.m. Pacific Time). Investors and interested parties can access a live webcast of the session through the Investor section of Seer's website at investor.seer.bio. An archived replay will be made available on the company's website after the conference concludes.

News Market Reaction – SEER

-1.31%

-1.31% Session move

In the trading session that priced this news, SEER declined 1.31%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming TD Cowen 45th Annual Healthcare Conference in Boston, MA.

Seer’s management is scheduled to participate in a fireside chat on Tuesday, March 4^th at 11:50 a.m. Eastern Time / 8:50 a.m. Pacific Time. A live webcast of the session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.

About Seer
Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph™ Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Media Contact:
Patrick Schmidt
pr@seer.bio

Investor Contact:
Carrie Mendivil
investor@seer.bio

FAQ

When is Seer (SEER) presenting at the TD Cowen Healthcare Conference 2025?

Seer is scheduled to participate in a fireside chat on Tuesday, March 4th, 2025, at 11:50 a.m. Eastern Time / 8:50 a.m. Pacific Time.

How can investors watch Seer's presentation at the TD Cowen Conference?

Investors can watch the live webcast through the Investor section of Seer's website at investor.seer.bio. An archived replay will also be available after the conference.

What type of presentation will Seer (SEER) give at the TD Cowen Healthcare Conference?

Seer's management will participate in a fireside chat format presentation at the conference.

Where is the TD Cowen Healthcare Conference featuring Seer taking place?

The TD Cowen 45th Annual Healthcare Conference is taking place in Boston, MA.